Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atypical Biopsy-Proven Myoglobin-Induced Acute Tubular Injury in the Setting of Normal Creatine Phosphokinase and Urine Myoglobin.

Cureus·2026
Same author

The Disappearing Act: A Case of Emphysematous Pyelonephritis and a Vanishing Kidney Allograft.

Case reports in transplantation·2026
Same author

Association of Urine-to-Plasma Urea Ratio with Outcomes in Patients with Chronic Kidney Disease: A Retrospective Cohort Study.

Nephron·2025
Same author

Crystalline Nephropathy Due to 2,8-Dihydroxyadeninuria in a Transplanted Kidney: 2 Case Reports.

The American journal of case reports·2025
Same author

Change Over Time in Pre-End-Stage Renal Disease 24-Hour Urine Creatinine as Muscle Mass Surrogate and Post-End-Stage Renal Disease Mortality.

Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation·2024
Same author

Malakoplakia in kidney transplant causing severe hydronephrosis and successful treatment with antibiotics and lowering immunosuppression.

Transplant infectious disease : an official journal of the Transplantation Society·2023

Related Experiment Video

Updated: Jun 11, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Cardiorenal risk factors.

Barry M Wall1

  • 1Veterans Affairs Medical Center and University of Tennessee Health Science Center, Memphis, Tennessee 38104, USA. Barry.Wall@va.gov

The American Journal of the Medical Sciences
|July 9, 2010
PubMed
Summary

Chronic kidney disease (CKD) significantly increases cardiovascular risk. Early assessment of glomerular filtration rate and albuminuria aids in stratifying patient risk for better cardiovascular outcomes.

Area of Science:

  • Nephrology
  • Cardiology
  • Public Health

Background:

  • Chronic kidney disease (CKD) is increasingly prevalent, affecting approximately 11% of the U.S. population.
  • CKD is linked to impaired cardiac function and structure, known as chronic renocardiac syndrome.
  • This syndrome elevates the risk of adverse cardiovascular events.

Purpose of the Study:

  • To highlight the association between CKD and adverse cardiovascular outcomes.
  • To emphasize the importance of CKD markers in risk stratification.
  • To advocate for the inclusion of CKD assessment in routine patient evaluation.

Main Methods:

  • Review of numerous studies demonstrating the link between CKD and adverse outcomes.
  • Analysis of CKD definition based on glomerular filtration rate and albuminuria.

More Related Videos

Multilevel Microdissection and Functional-Structural Profiling of Human Renal Arterial Branches
06:51

Multilevel Microdissection and Functional-Structural Profiling of Human Renal Arterial Branches

Published on: September 5, 2025

Related Experiment Videos

Last Updated: Jun 11, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Multilevel Microdissection and Functional-Structural Profiling of Human Renal Arterial Branches
06:51

Multilevel Microdissection and Functional-Structural Profiling of Human Renal Arterial Branches

Published on: September 5, 2025

  • Consideration of cost-effectiveness for diagnostic markers.

    • Main Results:

    • CKD, defined by reduced glomerular filtration rate and/or albuminuria, is consistently associated with adverse cardiovascular and renal outcomes.
    • These markers are readily available with minimal cost.

    Conclusions:

    • Albuminuria and glomerular filtration rate are crucial indicators for cardiovascular risk stratification.
    • Integrating CKD assessment with traditional cardiovascular risk factors can improve patient management.
    • Early identification and management of CKD are vital for preventing cardiovascular complications.